Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39.
Published February 26, 2020 · Recall initiated: January 28, 2020
Summary
FDA records drug Class II recall D-0850-2020, published February 26, 2020 and initiated January 28, 2020. Recalling firm: NCS Healthcare of Kentucky Inc; Status: Terminated; Reported quantity: 6929 blister cards; Lot: Lot #: 8170-9004, Exp 01/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- NCS Healthcare of Kentucky Inc
- Distributor
- Nationwide in the USA.
- Lot
- Lot #: 8170-9004, Exp 01/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALisinopril Tablets USP 20 mg, packaged in a) 15-count blister card (NDC 0615-7718-05), b) 30-count blisterNovember 29, 2023
- FDABuspirone Hydrochloride Tabs USP 10 mg, packaged in a) 15-count blister card (NDC 0615-7718-05) b) 30-countNovember 29, 2023
- FDADesmopressin Acetate Tablets, 0.2 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged andFebruary 26, 2020
- FDATramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottles (NDC 0093-0058-01), b)February 26, 2020
- FDADesmopressin Acetate Tablets, 0.1 mg, 30 tablets (3 x 10 unit dose blister cards), Rx Only, Packaged andFebruary 26, 2020
- FDAGlycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose Vial, Rx Only, For IntramuscularFebruary 26, 2020
Questions about this recall
Was Glycopyrrolate Tabs, USP, 1 mg, 30-count unit dose blister card, FOR INSTITUTIONAL USE ONLY, Rx Only, Packaged by Vangard, Glasgow, KY 42141; NDC 0615-8170-39. recalled?
Yes. FDA published recall D-0850-2020 on February 26, 2020. Reported hazard: Failed Impurities/Degradation Specification: High Out of Specification Results for Individual Unknown Impurity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter